21593201|inhibition|C0021467^C3463820^C0021469|start=0|end=10|PHYS^ACTI
21593201|plasminogen|C1367553|start=14|end=25|GENE
21593201|inhibitor|C1999216|start=36|end=45|CONC
21593201|skeletal muscle|C1546780^C1550659^C0242692^C1280260|start=57|end=72|CONC^ANAT
21593201|regeneration|C0349676^C0034963|start=73|end=85|PROC^PHYS
21593201|type 1|C0441729|start=99|end=105|CONC
21593201|mice|C1413131^C1417166|start=115|end=119|GENE
21593201|objective|C0018017^C1571702^C2979883|start=121|end=130|PHYS^CONC
21593201|type 1 diabetes|C0011854|start=132|end=147|DISO
21593201|leads|C0181586|start=148|end=153|DEVI
21593201|impairments|C2598156^C0684336|start=157|end=168|DISO^PHYS
21593201|growth|C2911660^C0220844^C0018270^C1621966|start=172|end=178|PHYS^ACTI
21593201|function|C0542341^C1315032^C1705273^C0031843|start=180|end=188|PHYS^CONC
21593201|capacity|C1516240|start=207|end=215|CONC
21593201|skeletal muscle|C1546780^C1550659^C0242692^C1280260|start=219|end=234|CONC^ANAT
21593201|mechanisms|C0441712|start=260|end=270|CONC
21593201|defined|C3539106^C1704788|start=293|end=300|CONC
21593201|research design|C0035171|start=302|end=317|PROC
21593201|methods|C0025664^C0449851^C0025663|start=322|end=329|CONC
21593201|use of|C1524063|start=340|end=346|CONC
21593201|mice|C1413131^C1417166|start=361|end=365|GENE
21593201|model|C0026336^C3714583^C3274659^C0026339^C3161035|start=367|end=372|DEVI^CONC
21593201|onset|C0332162|start=387|end=392|CONC
21593201|type 1 diabetes|C0011854|start=393|end=408|DISO
21593201|muscle regeneration|C0034964|start=411|end=430|ANAT
21593201|characterized|C1880022|start=435|end=448|ACTI
21593201|muscle|C0026845|start=461|end=467|ANAT
21593201|mass|C1546709^C2700045^C1306372^C1414542^C3152252|start=468|end=472|GENE^CONC
21593201|size|C0456389^C1552077^C1879945|start=483|end=487|CONC
21593201|area|C0205146^C0017446^C1510751|start=505|end=509|GEOG^ACTI^CONC
21593201|protein expression|C1171362|start=516|end=534|PHYS
21593201|blood plasma|C0032105|start=536|end=548|ANAT
21593201|analyzed|C0936012|start=553|end=561|PROC
21593201|glucose|C0337438|start=566|end=573|PROC
21593201|insulin|C0202098^C1337112^C2739803|start=602|end=609|PROC^GENE^PHYS
21593201|plasminogen|C1367553|start=615|end=626|GENE
21593201|inhibitor|C1999216|start=637|end=646|CONC
21593201|pai|C1698947^C1418252^C1705527|start=650|end=653|GENE^CONC
21593201|pai|C1698947^C1418252^C1705527|start=658|end=661|GENE^CONC
21593201|effective|C1704419^C1280519|start=670|end=679|CONC
21593201|inhibitor|C1999216|start=680|end=689|CONC
21593201|pai|C1698947^C1418252^C1705527|start=693|end=696|GENE^CONC
21593201|orally|C1527415^C0226896^C0442027|start=704|end=710|CONC^ANAT
21593201|administered|C1521801|start=711|end=723|CONC
21593201|pai|C1698947^C1418252^C1705527|start=740|end=743|GENE^CONC
21593201|muscle regeneration|C0034964|start=762|end=781|ANAT
21593201|mice|C1413131^C1417166|start=799|end=803|GENE
21593201|mice|C1413131^C1417166|start=828|end=832|GENE
21593201|exposed to|C0332157|start=833|end=843|PHYS
21593201|weeks|C0439230|start=851|end=856|CONC
21593201|type 1 diabetes|C0011854|start=870|end=885|DISO
21593201|chemically induced|C0007994|start=893|end=911|DISO
21593201|muscle injury|C0410256^C1998242|start=912|end=925|DISO
21593201|display|C1555465^C0870432^C1705417|start=926|end=933|OBJC^CONC
21593201|significant|C0750502^C1546944^C0237881|start=934|end=945|CONC
21593201|impairments|C2598156^C0684336|start=946|end=957|DISO^PHYS
21593201|capacity|C1516240|start=980|end=988|CONC
21593201|decreased|C0392756^C0205216^C0442797|start=1008|end=1017|CONC
21593201|muscle|C0026845|start=1018|end=1024|ANAT
21593201|mass|C1546709^C2700045^C1306372^C1414542^C3152252|start=1025|end=1029|GENE^CONC
21593201|area|C0205146^C0017446^C1510751|start=1056|end=1060|GEOG^ACTI^CONC
21593201|myogenin|C2986638^C1417575|start=1062|end=1070|GENE
21593201|myh3|C1417538|start=1076|end=1080|GENE
21593201|expression|C0185117^C0017262^C2911684|start=1081|end=1091|PROC^PHYS^CONC
21593201|pai|C1698947^C1418252^C1705527|start=1093|end=1096|GENE^CONC
21593201|physiologic|C0205463|start=1102|end=1113|CONC
21593201|inhibitor|C1999216|start=1114|end=1123|CONC
21593201|fibrinolytic system|C0814026|start=1131|end=1150|ANAT
21593201|primary|C0205225^C0439631|start=1155|end=1162|PROC^CONC
21593201|diabetes complications|C0342257|start=1184|end=1206|DISO
21593201|more than|C0439093|start=1212|end=1221|CONC
21593201|increased|C0442805^C0205217|start=1230|end=1239|CONC
21593201|2 weeks|C1442457|start=1247|end=1254|CONC
21593201|diabetes|C0011847^C0011849|start=1258|end=1266|DISO
21593201|onset|C0332162|start=1267|end=1272|CONC
21593201|elevated|C3163633^C0205250|start=1286|end=1294|CONC
21593201|experimental|C1517586|start=1310|end=1322|CONC
21593201|period|C1561960^C2347804^C1948053^C0025344^C0439531|start=1323|end=1329|PROC^PHYS^CONC
21593201|consistent with|C1524057^C0332290|start=1331|end=1346|CONC
21593201|increased|C0442805^C0205217|start=1347|end=1356|CONC
21593201|circulating|C0175630|start=1357|end=1368|CONC
21593201|pai|C1698947^C1418252^C1705527|start=1369|end=1372|GENE^CONC
21593201|regenerating|C0334213|start=1376|end=1388|CONC
21593201|muscles|C1995013^C0026845|start=1389|end=1396|ANAT
21593201|mice|C1413131^C1417166|start=1409|end=1413|GENE
21593201|excessive|C0442802|start=1424|end=1433|CONC
21593201|levels|C0441889|start=1443|end=1449|CONC
21593201|10 days|C1547061|start=1459|end=1466|CONC
21593201|concomitant|C0521115|start=1483|end=1494|CONC
21593201|decreases|C0547047^C0442797|start=1495|end=1504|CONC
21593201|active|C1553875^C1561510^C1706449^C1561511^C1561512^C1547419^C1561513^C1561507^C1561508^C1561509^C0205177^C2347179|start=1508|end=1514|PROC^CONC
21593201|urokinase|C1335224|start=1515|end=1524|GENE
21593201|plasminogen|C1367553|start=1525|end=1536|GENE
21593201|matrix|C0331858^C1704640^C1706515|start=1551|end=1557|ORGA^CONC^ANAT
21593201|pharmacologic|C0205464^C0031330|start=1579|end=1592|OCCU^CONC
21593201|inhibition|C0021467^C3463820^C0021469|start=1593|end=1603|PHYS^ACTI
21593201|pai|C1698947^C1418252^C1705527|start=1607|end=1610|GENE^CONC
21593201|orally|C1527415^C0226896^C0442027|start=1618|end=1624|CONC^ANAT
21593201|administered|C1521801|start=1625|end=1637|CONC
21593201|pai|C1698947^C1418252^C1705527|start=1638|end=1641|GENE^CONC
21593201|early|C1279919|start=1658|end=1663|CONC
21593201|impairments|C2598156^C0684336|start=1677|end=1688|DISO^PHYS
21593201|treated|C1522326|start=1703|end=1710|CONC
21593201|mice|C1413131^C1417166|start=1725|end=1729|GENE
21593201|conclusions|C1707478|start=1731|end=1742|CONC
21593201|taken|C1883727|start=1744|end=1749|CONC
21593201|data|C3245479^C1511726|start=1766|end=1770|DEVI^CONC
21593201|pharmacologic|C0205464^C0031330|start=1791|end=1804|OCCU^CONC
21593201|inhibition|C0021467^C3463820^C0021469|start=1805|end=1815|PHYS^ACTI
21593201|elevated|C3163633^C0205250|start=1819|end=1827|CONC
21593201|pai|C1698947^C1418252^C1705527|start=1828|end=1831|GENE^CONC
21593201|early|C1279919|start=1847|end=1852|CONC
21593201|impairments|C2598156^C0684336|start=1853|end=1864|DISO^PHYS
21593201|skeletal muscle|C1546780^C1550659^C0242692^C1280260|start=1868|end=1883|CONC^ANAT
21593201|repair|C0374711^C0043240^C1705181|start=1884|end=1890|PROC^PHYS
21593201|observed|C1441672|start=1891|end=1899|CONC
21593201|type 1 diabetes|C0011854|start=1903|end=1918|DISO
21593201|early|C1279919|start=1937|end=1942|CONC
21593201|interventional|C1948041^C3274035|start=1943|end=1957|PROC
21593201|studies|C0947630|start=1958|end=1965|PROC
21593201|targeting|C0599894^C1521840|start=1966|end=1975|PHYS^CONC
21593201|pai|C1698947^C1418252^C1705527|start=1976|end=1979|GENE^CONC
21593201|may|C3812381|start=1982|end=1985|CONC
21593201|ensure|C0218063|start=2002|end=2008|OBJC
21593201|optimal|C2698651^C3260738|start=2009|end=2016|CONC
21593201|growth|C2911660^C0220844^C0018270^C1621966|start=2017|end=2023|PHYS^ACTI
21593201|repair|C0374711^C0043240^C1705181|start=2028|end=2034|PROC^PHYS
21593201|skeletal muscle|C1546780^C1550659^C0242692^C1280260|start=2058|end=2073|CONC^ANAT
